Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can mindfulness tame diabetes distress and blood sugar?

NCT ID NCT07779044

Symptom relief Sponsor: Center for Strategic Studies and Health Training, Syria Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 28, 2026 · Updated 2 times

Summary

This trial tests whether a 14-week mindfulness-based cognitive behavioral program can improve quality of life and blood sugar control in adults with type 1 or type 2 diabetes. Participants will be randomly assigned to either the program or routine diabetes care. The study measures changes in quality of life and HbA1c levels to see if the program offers added benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A structured mindfulness-based cognitive behavioral program delivered over 14 weekly sessions
What this could lead to
If effective, this program could offer a non-drug way to help people with diabetes improve their emotional well-being and better manage blood sugar levels.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply broadly. The program requires significant time commitment, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Oct 2025

Finished

Jan 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-70 years. * Diagnosis of type 1 or type 2 diabetes mellitus. * Baseline HbA1c level greater than 6.5%. * Mild to moderate depressive symptoms according to the Beck Depression - -Inventory (BDI). * Ability to understand the study procedures and intervention instructions. * Willingness to participate in all intervention sessions. * Ability and willingness to provide written informed consent. Exclusion Criteria: * Severe psychiatric disorders requiring specialized psychiatric care. * Acute medical conditions that could prevent participation in the intervention. * Receiving regular psychotherapy or another similar psychological intervention. * Inability to understand the intervention instructions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depressive symptoms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Depression diabetes mellitus type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Depressive symptoms Diabetes mellitus Diabetes mellitus ( type 1 and type 2)

Contacts and locations

Locations

  • Center for Strategic Studies and Health Training

    Damascus, Damascus Governorate, Syria

More trials for these conditions

Other studies related to the condition(s) this trial covers.